logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Ofsted rigor – outstanding results?

10 September 2013

The head of Ofsted, Sir Michael Wilshaw, has reported that over the last year the number of schools rated as good or outstanding by Ofsted has risen at an unprecedented rate – up by 9% to 78%. The headline figure is however tarnished by the other figures that showed the number of schools rated as inadequate as staying roughly the same. Ofsted have claimed that their changes to inspection and the replacement of the “satisfactory” rating with “requires improvement” has given a clear message to schools about the need to continually improve.

Whilst this improvement is clearly good news, it may be too simplistic to solely emphasise Ofsted’s role. The education sector is going through great change and the increase in autonomy and accountability, the rise of school to school support through academy chains or federations and trust may well have played a role. Whatever the reason, more good schools will be welcome news to parents, prospective employers and government alike.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up